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Schistosoma mansoni causes liver disease by inducing granulo-
matous inflammation. This favors formation of reactive oxygen
species, including superoxide ions, hydrogen peroxide and hy-
droxyl radicals all of which may induce lipid peroxidation. We have
evaluated lipid peroxidation in 18 patients with hepatosplenic schis-
tosomiasis mansoni previously treated with oxamniquine followed
by splenectomy, ligature of the left gastric vein and auto-implanta-
tion of spleen tissue, by measuring levels of erythrocyte-conju-
gated dienes and plasma malondialdehyde (MDA). Age-matched,
healthy individuals (N = 18) formed the control group. Erythrocyte-
conjugated dienes were extracted with dichloromethane/methanol
and quantified by UV spectrophotometry, while plasma MDA was
measured by reaction with thiobarbituric acid. Patient erythrocytes
contained two times more conjugated dienes than control cells
(584.5 ± 67.8 vs 271.7 ± 20.1 µmol/l, P < 0.001), whereas the increase
in plasma MDA concentration (about 10%) was not statistically
significant. These elevated conjugated dienes in patients infected
by S. mansoni suggest increased lipid peroxidation in cell mem-
branes, although this was not evident when a common marker of
oxidative stress, plasma MDA, was measured. Nevertheless, these
two markers of lipid peroxidation, circulating MDA and erythro-
cyte-conjugated dienes, correlated significantly in both patient (r =
0.62; P < 0.01) and control (r = 0.57; P < 0.05) groups. Our data show
that patients with schistosomiasis have abnormal lipid peroxida-
tion, with elevated erythrocyte-conjugated dienes implying dys-
functional cell membranes, and also imply that this may be attenu-
ated by the redox capacity of antioxidant agents, which prevent
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Schistosomiasis mansoni is endemic in
northeast Brazil, mainly in rural areas of
Pernambuco. The disease is also extending
to new areas, for example the vacation island
of Itamaracá, 50 km to the north of Recife
(1), as infected people migrate. Patients with
severe infections frequently develop peripor-
tal fibrosis, portal hypertension and hepato-
splenomegaly and, classically, are surgically
treated by splenectomy, accompanied by
obliterating suture of esophageal varices and
ligature of the left gastric vein (2). In the last
decade, auto-implantation of spleen tissue in
children has been carried out with the sur-
gery and this has improved liver function and
increased survival time (3). Among tropical
diseases, Schistosoma mansoni is the second
major cause of morbidity and mortality world-
wide (2) and persists mainly in developing
countries, with significant economic and
public health consequences (1). Morbidity
depends on genetic and environmental fac-
tors, as well as severity of infection, and all
three influence the granulomatous inflamma-
tion of the liver and later fibrosis around the
eggs (2).
Eosinophil cells associated with schisto-
some-induced granulomas form oxygen free
radicals, such as superoxide and hydroxyl
radicals (4), and release active eosinophil
peroxidase around the egg granulomas (5).
However, the consequences of free radical
generation in schistosomiasis mansoni are
still unknown. This also applies to the effects
on lipid peroxidation, where polyunsaturated
fatty acids and other lipids are oxidized by
intermediate free radicals to form conjugated
dienes, malondialdehyde (MDA) and lipid
hydroperoxides, among other products (6).
MDA is the most abundant aldehyde pro-
duced during lipid peroxidation, and its assay
is often used as a marker for oxidative stress
in several diseases (7), including Alzheimer’s
disease, atherosclerosis and diabetes (8). In
liver disease, free radicals have been impli-
cated in the inflammatory process, and in-
creased lipid peroxidation has been found
(9). Lipid peroxidation starts with abstrac-
tion of OH• • • • •  from a -CH2- group of polyun-
saturated fatty acids, where the carbon radi-
cal is usually stabilized by a molecular rear-
rangement forming conjugated dienes, com-
pounds containing two double bonds sepa-
rated by a single bond. Conjugated dienes
react with O2 forming peroxyl radicals that
react with OH• • • • • atoms from other lipids,
producing lipid hydroperoxides or forming
cyclic peroxides, and several products are
formed, including MDA (6). In mice, the
antioxidant capacity of livers damaged by S.
mansoni is reduced, and this results in gen-
eration of lipid peroxides (10).
The aim of the present study was to
evaluate lipid peroxidation in patients with
schistosomiasis mansoni who were submit-
ted to clinical and surgical treatment, meas-
uring levels of plasma MDA and erythrocyte-
conjugated dienes.
Thiobarbituric acid, MDA and methanol
were obtained from Sigma (St. Louis, MO,
USA) and dichloromethane and trichloroace-
tic acid from Vetec (Rio de Janeiro, RJ,
Brazil). All other solvents and chemicals
were of analytical grade.
Young patients (11-20 years; N = 18) of
both genders with hepatosplenic schistoso-
miasis mansoni, who had had upper digestive
bleeding but no renal, cardiac, hepatitis, or
other parasite/microbial associated disease
were included in this study. They were
outpatients at the Clinical Hospital, Federal
University of Pernambuco (UFPE), Recife,
and had been treated with the antischistosomal
drug, oxamniquine (a single dose of 20 mg/
kg) followed by splenectomy, ligature of the
left gastric vein and auto-implantation of
spleen tissue into an omental pouch of the
major omentum. The study was conducted
on patients 3 to 6 years after the surgical
procedure. Patients had generally developed
normally, although development improved
after treatment, as did their indicators of liver
function, especially serum albumin concen-
tration and prothrombin time (3). Body mass959
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index (BMI) was calculated as the body
weight (kg) per height2 (m2). None of the
women in either group were pregnant or
used oral contraceptives. The study was
approved by the Ethics Committee of the
University Hospital, UFPE (Process number
193/99-CEP/CCS) and written informed
consent was obtained from all patients and
volunteers used as controls.
Early morning blood samples were col-
lected into ice-cold tubes containing EDTA
(1 mg/ml) and erythrocytes and plasma were
isolated by centrifugation at 3,000 g for 15
min at 4ºC. As storage at -20ºC may increase
lipid peroxidation, duplicate samples were
analyzed immediately. Plasma thiobarbituric
acid reactive substance (TBARS) were meas-
ured by the method of Buege and Aust (11),
mixing aliquots with 15% (w/v) trichloro-
acetic acid and 0.375% (w/v) thiobarbituric
acid and heating at 100ºC for 15 min. Samples
were cooled to room temperature, centri-
fuged at 3,000 g for 5 min and their absorb-
ance was measured at 535 nm against a
reaction mixture lacking plasma but sub-
jected to the same procedure. As in other
studies (12), levels of TBARS are reported as
nmol of MDA per liter of plasma, using a
standard curve prepared with MDA bis (di-
ethyl acetal) as the MDA reference source.
Conjugated dienes in washed erythrocytes
were extracted with dichloromethane/metha-
nol (2:1, v/v) and measured by the method of
Buege and Aust (11). A solution of 50 mM
potassium chloride was then added and, after
the preparation was left to stand overnight at
4ºC, the concentration of conjugated dienes
in the lower phase was measured by absorb-
ance at 233 nm against dichloromethane
(11).
Results were analyzed by the unpaired
Student t-test and Pearson’s correlation co-
efficient; both were calculated using the
Origin software program version 5.0, and
differences were considered significant for
P < 0.05. Data in the text are reported as
means ± SEM. No gender-related difference
was observed in the correlation analysis and
so data for both genders were used as a single
group.
Most studies exclude patients considered
to be malnourished, usually based on BMI
scores or on plasma protein and hemoglobin
levels. Here, we used BMI and dietary history
to exclude malnourished patients. All patients
included lived at home with their mother or a
caregiver responsible for preparing food,
and no significant changes in their dietary
habits were noted as a result of the disease.
In addition, the BMI of our patients (19.3 ±
1.2 kg/m2) did not differ from the control
group (21.7 ± 0.5 kg/m2; P > 0.05).
One indicator of lipid peroxidation, plasma
MDA concentration, was increased by 10%
in patients with schistosomiasis mansoni
(Figure 1A), but the rise was not significant.
However, levels of conjugated dienes extract-
ed from patient erythrocytes were signifi-
cantly increased by about 100% (P < 0.001)
in comparison to the control group (Figure
1B). Moreover, these two markers of lipid
peroxidation, circulating MDA and erythro-
cyte-conjugated dienes, were significantly
correlated in both patient (r = 0.62; P < 0.01)
and control (r = 0.57; P < 0.05) groups
(Figure 2).




































































Figure 1. Concentration of lipid
oxidation products in plasma
and erythrocytes of patients
with hepatosplenic schistoso-
miasis mansoni. Plasma malon-
dialdehyde (A) and erythrocyte-
conjugated diene (B) levels in
18 patients with schistosomia-
sis, who had been treated by
splenectomy, obliterative suture
of the esophageal varices, liga-
ture of the left gastric vein, and
auto-implantation of spleen tis-
sue. *P < 0.05 compared to
controls (unpaired Student t-
test).960
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miasis range from the mild intestinal form to
severe hepatosplenic forms associated with
esophageal varicose veins and upper diges-
tive bleeding. Infection caused by S. mansoni
can induce granulomatous inflammation of
the liver and lead to formation of certain
reactive oxygen species, such as superoxide
ions (O2
• • • • •-) and hydroxyl radicals (OH• • • • •).
These promote lipid peroxidation (4), an
adverse event which contributes to the pa-
thology associated with schistosomiasis. Li-
pid peroxidation is a complex and relatively
imprecise series of reactions leading to a
diverse array of bioactive molecules, many
still ill-defined (6). Perhaps not surprisingly,
given its complexity, there is no clear agree-
ment on how best to quantify lipid peroxida-
tion and the techniques used range from
relatively crude measures to more sophisti-
cated analyses of individual products using
HPLC and/or mass spectrometry. As our
study is the first investigation of lipid peroxi-
dation in patients with schistosomiasis, we
chose two practical assays for oxidative
stress, i.e., plasma TBARS and erythrocyte-
conjugated dienes. These markers correlate
closely with other methods commonly used
to detect lipid peroxidation and are well-
characterized and reliable indicators (7,13).
However, while the TBARS assay is fre-
quently used as a measure of MDA, with data
expressed as nmol MDA per liter plasma
(12,14) as we did in the present study, the
assay is not specific for MDA since other
compounds including sugars, amino acids
and bilirubin may cross-react with thiobarbi-
turic acid. Thus, in future studies it may be
preferable to use HPLC, a more precise
though complex analysis (14).
In the present study, we found clear
evidence of lipid peroxidation in erythrocytes
from patients with schistosomiasis mansoni,
who had undergone clinical and surgical
treatment, as judged by their significantly
high content of conjugated dienes, products
which reflect the initial phase of lipid peroxi-
dation. On the other hand, when the degrada-
tive phase of lipid peroxidation was examined
in the plasma of these patients, assaying
TBARS as a measure of MDA levels, there
was no significant increase compared to
normal subjects.
The increased lipid peroxidation in patient
erythrocytes seems to be a consequence of
the disease rather than of clinical treatment
with oxamniquine. Indeed, plasma MDA lev-
els were not altered in S. mansoni-infected
mice treated with praziquantel, a drug used to
kill the parasite (15). Furthermore, our pa-
tients did not have granulomatous inflamma-
tion, which is known to increase lipid peroxi-
dation and raise levels of conjugated dienes
(4). However, our patients do still have
moderate liver disease, and in a study of mild
alcohol-induced liver damage lipid peroxida-
tion was detected by various indicators of
oxidative stress, even though plasma MDA
levels were normal (16).
Erythrocytes constitute a well-established
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Figure 2. Correlation between
plasma malondialdehyde and
erythrocyte-conjugated dienes.
A, Patients with schistosomiasis
mansoni. B, Healthy individuals
(control group). Data were ana-
lyzed by the Pearson correlation
method.961
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branes by chemical and physical free radical
promoters. As shown here, schistosomiasis
mansoni may induce chemical damage to
erythrocyte membranes through an oxida-
tive stress pathway. Superoxide anion, sin-
glet oxygen and H2O2 can all contribute to
erythrocyte lipid oxidation with the forma-
tion of intermediate conjugated dienes pre-
ceding that of aldehyde products (TBARS).
The reactions begin when the main endoge-
nous lipophilic antioxidant, vitamin E, is ex-
tensively consumed and in experimental schis-
tosomiasis mansoni vitamin E supplementa-
tion lowers the activity of catalase and gluta-
thione peroxidase, liver enzymes involved in
antioxidant mechanisms (17). In the present
study, schistosomiasis appeared to promote
lipid peroxidation, as measured by increased
erythrocyte-conjugated diene concentration.
However, excessive plasma MDA was not
produced, perhaps because reduced gluta-
thione (GSH) and protein thiols were pre-
served, although, as yet, the redox capacity
of GSH/oxidized glutathione (GSSG) and
antioxidant levels of vitamin E and C have not
been measured in human schistosomiasis.
Thus, although we have examined two blood
markers of oxidative stress in this prelimi-
nary study of patients with schistosomiasis,
it will be important in future studies to deter-
mine how changes in lipid peroxidation mark-
ers relate to the disease process and to
reductions in antioxidant defenses, including
the consumption of ascorbate and other
antioxidant nutrients during free radical scav-
enging. For example, in elderly people blood
antioxidant defenses are significantly reduced,
and in patients with unstable hemoglobin
disorders or low levels of glucose-6-phos-
phate dehydrogenase the erythrocytes are
susceptible to oxidative attack, predisposing
them to drug- or infection-mediated hemo-
lytic crises. Furthermore, when hepatic granu-
lomas develop in experimental schistosomia-
sis they trigger production of reactive oxy-
gen species which alter the antioxidant de-
fense profile (5).
Our finding of a positive correlation be-
tween plasma MDA and erythrocyte-conju-
gated dienes supports the use of these routine
and practical assays as a means of identifying
and monitoring patients susceptible to severe
lipid peroxidation in schistosomiasis. The
correlation is also consistent with a mechan-
ism of a reactive oxygen species-induced
lipid peroxidation process in which polyun-
saturated fatty acids undergo hydrogen ab-
straction by free radical attack to form con-
jugated dienes (6,9), which are further at-
tacked to generate MDA or lipid hydroperox-
ide. Thus, conjugated dienes are intermedi-
ates during MDA production and this could
explain the positive and significant correla-
tion between them, both in patients and
control groups. However, we recently re-
ported a significant reduction in activity of
lecithin-cholesterol acyltransferase, the
plasma enzyme which esterifies cholesterol
and helps regulate cell membrane lipid com-
position, in patients with schistosomiasis
who had undergone the same clinical and
surgical treatments as the patients in the
present study (18). This thiol-containing
enzyme is highly sensitive to several oxidiz-
ing species, either directly or by cross-
linking of its co-factor, apoAI (19), and so
oxidative stress may contribute to the ac-
quired lecithin-cholesterol acyltransferase
deficiency and membrane disturbances (20)
seen in human schistosomiasis.
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